Obstructive Sleep Apnoea Therapy Decreases Cardiovascular Risk
Main Category: Sleep / Sleep Disorders / InsomniaAlso Included In: Respiratory / Asthma; Ear, Nose and Throat; Cardiovascular / Cardiology
Article Date: 27 Nov 2008 - 3:00 PDT
| Patient / Public: | ![]() |
2 (1 votes) |
| Healthcare Prof: | ![]() |
5 (3 votes) |
Obstructive sleep apnoea syndrome (OSAS) is a sleep disorder characterised by snoring, repetitive apnoeas associated with oxygen desaturations, and sleep disruption. It has been estimated that 2-4% of the adult population in Western countries suffer from clinically significant OSAS.
OSAS has also been associated with high blood pressure, stroke and myocardial ischaemia in epidemiological and observational studies. Continuous positive airway pressure (CPAP) is the treatment of choice for OSAS, but the impact of this therapy on established risk factors for cardiovascular disease is largely unknown.
In this study conducted in Oxford, UK, Malcolm Kohler (Oxford Centre for Respiratory Medicine) and his colleagues randomised 102 men with OSAS to CPAP or placebo CPAP treatment for four weeks in order to investigate the effects of CPAP on measures of cardiovascular risk, such as sympathetic nerve activity, arterial stiffness and blood pressure.
They found that one month of CPAP therapy reduced sympathetic nerve activity by 26%, lowered arterial stiffness by a third, and significantly decreased blood pressure when compared to placebo CPAP.
The findings of this study suggest that treatment of OSAS patients with CPAP may have a positive impact on patient's survival by effectively reducing a number of well-established risk factors for cardiovascular disease.
TITLE OF THE ORIGINAL ARTICLE
CPAP and measures of cardiovascular risk in males with OSAS.
About the European Respiratory Journal (ERJ)
The European Respiratory Journal is the peer-reviewed scientific publication of the European Respiratory Society (more than 8,000 specialists in lung diseases and respiratory medicine in Europe, the United States and Australia).
European Respiratory Journal
Visit our sleep / sleep disorders / insomnia section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/131043.php>
APA
http://www.medicalnewstoday.com/releases/131043.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




